Rockefeller Capital Management
DCPH

Rockefeller Capital Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Rockefeller Capital Management’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-200
Closed -$3K – 4049
2022
Q4 		$3K Hold
200
– – ﹤0.01% 3512
2022
Q3 		$3K Hold
200
– – ﹤0.01% 3530
2022
Q2 		$2K Hold
200
– – ﹤0.01% 3863
2022
Q1 		$1K Hold
200
– – ﹤0.01% 3806
2021
Q4 		$1K Buy
+200
New +$3.76K ﹤0.01% 3712

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Rockefeller Capital Management's DCPH Position: Q1 2023 in Review

Rockefeller Capital Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2023, closing a stake of 200 shares — an estimated $3K sold.

Rockefeller Capital Management first reported a position in DCPH in Q4 2021 and held it in 5 quarters. The position peaked at $3K in Q4 2022. 146 funds tracked by Wall St. Rank hold DCPH as of Q1 2023.

  • Rockefeller Capital Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Rockefeller Capital Management sold 200 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2023, an estimated $3K.
  • Rockefeller Capital Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 5 quarters.
  • Rockefeller Capital Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $3K in Q4 2022.
  • 146 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2023.

Based on Rockefeller Capital Management's 13F filing for Q1 2023, filed 16 May 2023.